| CNS
& Neurological Disorders - Drug Targets
(Formerly 'Current Drug Targets - CNS & Neurological
Disorders')
ISSN: 1871-5273 - Volume 7, 6 Issues, 2008
Instructions for Authors
Online Manuscript Submission: Manuscripts
must only be submitted online to the Bentham Science Editorial
Office. It is preferable that authors first send an abstract
to the editor, prior to submitting the full manuscript. The
submitted abstract should outline the intended contents and
coverage of the article. Abstracts may be sent either by e-mail
to the editorial office at editorial@cnsnd-dt.org
or alternatively by the Internet at www.bentham.org/onlAbsSub.htm.
A successful electronic submission of a manuscript will be
followed by a system-generated acknowledgement to the principal/corresponding
author within 72 hours of the dispatch of the manuscript.
Any queries therein should be addressed to mahmood@bentham.org
and copied to Jalil@bentham.org.
After approval of your abstract by the editor, you may submit
your full manuscript either by e-mail (file size restricted)
or by online submission. For online submission of manuscripts,
these should be submitted via our online manuscript submission
service available at www.bentham-mps.org
or by FTP submission at www.bentham-ftp.org.
For all online submissions, please provide your complete manuscript
in the form of a single zipped folder containing soft copies
of all the material (main text in MS word format, figures
/ illustrations, scanned photographs, tables, chemical structures
drawn in ChemDraw) as separate files, while a PDF version
of the entire manuscript must also be included with all the
figures / illustrations / tables / chemical structures etc.
embedded in the text exactly in the manner as they should
appear in print.
Authors are required to proofread the PDF version of their
manuscript before submission. The Publishers will not be responsible
for any error occurring in the manuscript in this regard.
Manuscripts fall under two categories:
1. Invited Reviews (Full length & Mini-reviews)
The focus will either be a therapeutic target or a molecular
target which may be a single protein or a family of proteins.
The authors will have considerable liberty to discuss such
areas as genomics, polymorphisms, molecular biology, creation
and use of stable cell lines, target validation (e.g. cellular
and sub-cellular distribution of the molecular target, embryonic
and functional knockout animal models, antisense and aptamer
studies), high throughput screening and drug discovery, rational
drug design, drug discovery and development, and the results
of clinical trials that shed light on the relationship between
the molecular and therapeutic target. Manuscripts will be
reviewed by at least two reviewers to ensure that only articles
of the highest scientific quality appear in CDT-CNSND.
2. Unsolicited Reviews (Full length & Mini-reviews)
Manuscripts on any topic related to CNS drug targets will
be considered by the CDT-CNSND editorial team.
For full length review articles, the manuscript, written in
English, should not exceed 60 pages (ca. 30 printed pages)
and for mini-reviews a maximum of 30 manuscript pages in length
(ca. 15 printed pages).
The manuscript should be typed in double spacing throughout
on A-4 or US Letter (8.5x11 inches) paper.
Dot matrix print or any print that is difficult to read is
unacceptable. Two copies of the manuscript must accompany
the original (along with a passport size black and white photograph
of the author and a computer disk) and should be sent to the
Editor-in-Chief’s address. All pages should be numbered.
Abbreviations should be defined the first time that they are
used in the manuscript and a list of abbreviations used should
be provided (see below).
Single Topic Issues: These issues will be restricted to invited
review articles. A Single Topic Special Editor will offer
a short Perspective and co-ordinate the solicitation of manuscripts
from leading scientists. Single Topic Issues will focus on
either a molecular target or a specific disease or family
of diseases. In the latter case, the less well addressed CNS
disorders will be highlighted. Authors interested in editing
a single topic issue may submit their proposal to the Editor-in-Chief
for his consideration.
Manuscript Organisation: The manuscript should be divided
as: Title page, abstract and the main text. The text may be
subdivided further according to the areas to be discussed.
This should be followed by the Acknowledgement (if any) and
Reference sections. The first page should contain the title,
the authors’ names (initials and surname only), with
an asterisk in front of the name of the principal author.
Conflict of Interest: Financial contributions
to the work being reported should be clearly acknowledged,
as should any potential conflict of interest.
Abstract: The abstract should not exceed 250 words
and it should condense the essential features of the review
article, with the focus on the major advances in the field.
Key Words: Authors must supply up to eight key words
along with their manuscript.
Text: The main text should begin on a separate page
and it may be subdivided into separate sections. The review
article should mention any previous important reviews in the
field and contain a comprehensive discussion starting with
the general background of the field. It should then go on
to discuss the salient features of recent developments. The
authors should avoid presenting material which has already
been published in a previous review. The reference numbers
should be given in square brackets in the text. Acknowledgements
should be kept to a minimum.
Abbreviations: All abbreviations used in the text must
be listed and defined in a separate section following the
acknowledgements and before the reference section. Only use
abbreviations that are widely accepted in the scientific community.
Tables: -
Data Tables should be submitted in Microsoft Excel or in Microsoft Word table
format.
- Each table should include
a title/caption explaining what the table shows. Detailed legends may then follow.
-
Tables should be given on separate pages with indications on the left hand margin
to the text, as to the appropriate placement of the tables.
-
Tables should not contain vertical rules.
-
Columns and rows of data should be made visibly distinct by ensuring the borders
of each cell display as black lines.
-
Tables should be numbered consecutively in order of their citation in the body
of the text, with Arabic numerals.
-
If a reference is cited in both the table and text, insert a lettered footnote
in the table to refer to the numbered reference in the text.
-
Tabular data provided as additional files can be submitted as an Excel spreadsheet.
Figures
/ Illustrations:
All authors must strictly follow the guidelines below for
preparing illustrations for publication in CNS & Neurological
Disorders - Drug Targets
Editorial
Requirements: The quality of the illustrations printed in the journal
largely depends on the quality of the figures/illustration provided by the author.
In preparing artwork or graphics for publication, keep in mind the following points.
- Submit the original artwork or a photographic
print of the original for publication.
- Do not submit photocopies. (Hardcopy submission
requirement).
- Illustrations should be provided as separate
files, not embedded in the text. (Hardcopy submission requirement).
- Remove all color from graphics except for
those illustrations (Greyscale), which are intended to be
printed in color.
- Good quality of hardcopy originals are a
requirement.
- Figures should be referred to as “Fig.
(1)”, “Fig. (2)” etc. in the
text with figure numbers in bold within round bracket.
- Revised manuscripts should contain a complete
set of artwork and photographs.
Technical
Details:
- Figures should be provided on high quality,
white, smooth opaque paper. (Hardcopy requirement).
Format
& Resolution:
- The following file formats can be accepted.
(Preference in order of appearance): PDF, TIFF, JPEG, GIF.
- Illustrations
must fit a single or double column format on the journal page, according to the
following guideline below:
|
HEIGHT | WIDTH |
SINGLE COLUMN |
24 cm (max) |
8.5 cm (max) | DOUBLE
COLUMN | 24
cm (max) | 18
cm (max) |
- Whenever possible, submit
graphics that do not have to be reduced to fit the standard figure size.
-
Use the best resolution available (hardcopy submission requirement). For online
submission the maximum resolution is 300 dpi.
- Avoid textures
and shadings giving a three-dimensional effect to the illustration.
-
Symbols and lettering in the illustration should be of similar size.
-
Smaller lettering is used.
- Font: Times New Roman or Helvetica is preferable.
Font size: 10pt (maximum).
- Line drawings should
have clear and sharp lines and should be of uniform density. Moreover, lines should
be continuous without any breaks.
- Do not use lines thinner
than 1 point.
Color Figures / Illustrations:
Photographs:
Submit high-contrast prints that are of single- or double-column
width so that they will not have to be reduced when printed.
Negatives are not acceptable. However, in case of hardcopy
submission, color illustrations and plates can be published
from 35 mm color slides.
Chemical Structures: Chemical structures must be prepared
according to the guidelines below.
Structures should be prepared using a suitable drawing program
e.g. ChemDraw and provided as separate file, submitted both
on disk and in printed formats.
Numbers in bold should identify all chemical structure. If
a name is also used to describe the compound, the associated
number in bold should be in parenthesis, e.g. “compound
(1)”.
Structure Drawing Preferences:
[As according to the ACS style sheet] Drawing
Settings:
Chain angle 120°
Bond spacing 18% of width Fixed length 14.4
pt (0.500cm, 0.2in) Bold width
2.0 pt (0.071cm, 0.0278in) Line width
0.6 pt (0.021cm, 0.0084in) Margin width
1.6 pt (0.096cm) Harsh spacing 2.5 pt (0.088cm, 0.0347in) Text
settings: Font Times
New Roman / Helvetica Size 10pt Under
the Preference Choose: Units
points Tolerances 3
pixels Under Page Setup Use: Paper US
letter Scale
100%
References: The reference
numbers in normal font should be given in square brackets
in the text (e.g. [1]), then collected at the end of the manuscript
in numerical order. For the format of references, see the
ACS Style Guide, pp 106-114,
Examples:
Journal Reference:
Barton, D.H.R.; Brewster, A.G.; Ley, S.V.; Rosenfield,
M.N. J. Chem. Soc. Chem. Commun., 1977, 147,
2356.
Book Reference:
Rahman, A.-U.; Shah, Z. Stereoselective Synthesis in Organic
Chemistry, Springer-Verlag: New York, 1993.
Book Chapter Reference:
Wheeler, D.M.S.; Wheeler, M.M. In Studies in Natural
Products Chemistry; Atta-ur-Rahman, Ed.; Elsevier Science
B. V: Amsterdam, 1994; Vol. 14, pp. 3-46.
Abstracts, unpublished data and personal communications (which
can only be included if the permission has been obtained)
should not be given in the reference section but they may
be mentioned in the text with details provided as footnotes.
All authors of referenced papers must be cited and there must
be no use of the short hand version of et al. when citing
the authors.
Page Charges: No page charges will be levied to authors.
Language Editing: Manuscripts submitted containing
many English typographical errors will not be published. Authors
from non-English language countries are advised to use the
services of our professional language editing department prior
to submitting their manuscript to the Journal. Please contact
Bentham Publishing Services www.benthampublishingservices.com
for a language editing quote at e-mail: info@benthampublishingservices.com
stating the total number of words of the article to be edited.
Proofs: Authors are sent page proofs. To
avoid delays in publication, proofs should be checked immediately
for typographical errors and returned within 48 hours. Authors
will be charged for excessive changes made at the page proof
stage.
Reprints: Each first named author will receive
by e-mail a free copy of their article as a PDF file. The
PDF file is a watermarked version of the published article
which is exclusively for the author's own use and may not
be copied or distributed. Reprints may be ordered from the
Publisher prior to publication of the article. First named
authors may also order a personal print and online subscription
of the journal at 50% off the normal subscription rate by
contacting the subscription department at e-mail: subscriptions@bentham.org
Bentham Open Access: Accepted articles can
be published online for free open access for all to view.
Open access publishing provides the maximum dissemination
of the article to the largest audience. Authors must pay for
this service. All corresponding authors will be asked to indicate
whether or not they wish to pay to have their paper made freely
available on publication. If authors do not select the Open
Access option, then their article will be published with standard
subscription-based access at no charge. Open access articles
are published under the terms of the Creative Commons Attribution
Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)
which permits unrestricted, non-commercial use, distribution
and reproduction in any medium, provide the work is properly
cited.
Bentham Science offers authors the choice of open access publication
of their articles at a fee of US$ 1,500
per published article which allows indefinite online
publication with BOTH Bentham Science and PubMed Central.
For authors who select this option, Bentham Science will undertake
to deposit these articles in PubMed Central and to make these
freely available on publication.
Alternatively, authors may choose to publish their article
with Bentham Science at a reduced fee for a limited open access
period. Bentham Science is the first and only publisher to
offer authors the choice at a reduced open access fee to have
their article published for a limited open access period.
For open access publication for a period of twelve months
(limited open access) the per article fee is US$
750 . For more information please contact us at e-mail:openaccess@bentham.org
Reviewing and Promptness of Publication:
All papers submitted for publication will be immediately subjected
to editorial scrutiny, usually in consultation with members
of the Editorial Advisory Board. Every effort will be made
to assess the papers quickly. The papers will be typeset and
the proofs dispatched to the authors normally within 4 weeks
of their acceptance.
Copyright: It is a condition of publication
that manuscripts submitted to this journal have not been published
and will not be simultaneously submitted or published elsewhere.
Plagiarism is strictly forbidden, and by submitting the article
for publication the authors agree that the publishers have
the legal right to take appropriate action against the authors,
if plagiarism is discovered. By submitting a manuscript the
authors agree that the copyright of their article is transferred
to the publishers if and when the article is accepted for
publication.
|
